Moderators:

• Emma Barber, MD, Northwestern University, Chicago, IL
• Robert Morris, MD, Wayne State University, Detroit, MI

Distillant:

• Anna Fagotti, MD, PhD, Catholic University of the Sacred Heart, Rome, Italy

Speakers:

• Se Ik Kim, MD, Seoul National University Hospital, Seoul, South Korea
• Pedro Ramirez, MD, University of Texas MD Anderson Cancer Institute, Houston, TX

Panelists:

• Se Ik Kim, MD, Seoul National University Hospital, Seoul, South Korea
• Amanda Nickles Fader, MD, Johns Hopkins Medical Center, Baltimore, MD
• Pedro Ramirez, MD, University of Texas MD Anderson Cancer Institute, Houston, TX
• Alejandro Rauh-Hain, MD, University of Texas MD Anderson Cancer Institute, Houston, TX

Location: Kamehameha 3

Description: This session will explore recent updates to the use of minimally invasive surgery in cervical cancer and effects on survival. Updates from the LACC trial, new data from Korea, China and the United States, as well as a panel to discuss how to clinically incorporate these changes will all be discussed.

ABSTRACT 17
Minimally invasive surgery versus laparotomic surgery as a primary treatment for patients with stage IA1-IIA2 cervical cancer

S.I. Kim1, M. Lee1, H.S. Kim2, N.H. Park1 and J.W. Kim2,3
1Seoul National University Hospital, Seoul, South Korea, 2Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea, 3Korean Gynecologic Oncology Group (KGOG), Seoul, South Korea